CAMBRYN BIOLOGICS ANNOUNCES COMPLETION OF CONTRACT DEVELOPMENT MANUFACTURING AGREEMENT AND FILING OF PATENT

SARASOTA, Florida –November 15, 2015, Mark P. Famiglio, CEO of Cambryn Biologics, a privately held Delaware corporation, announces that the Company successfully completed a Contract Development Agreement with Abeona Pharmaceuticals, and accordingly filed a provisional patent; the agreement provided a non-exclusive license agreement to the technology.

The project began in February 2015, and consisted in developing a plasma derived protein Alpha 1 Protease Inhibitor based on a salting process in lieu of the Cohn alcohol based extraction. The downstream process incorporated innovative affinity chromatography which led Cambryn to file a new provisional in October 2015.

About Cambryn

Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies, advanced wound healing and biosurgical hemostats. The Company specializes in the extraction and purification of human plasma proteins. Cambryn operates a 50,000 square foot state-of-the-art cGMP facility, which incorporates cleanrooms and laboratories.

For additional information contact:
Cambryn Biologics LLC
Mark P. Famiglio
Chief Executive Officer
600 Tallevast Rd – Suite 201
Sarasota, Florida USA 34243
Office: 941-355-7400
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.cambrynbiologics.com

Cambryn Biologics LLC

Cambryn Biologics LLC is a Delaware corporation having its principal facility and offices in Sarasota, Florida. Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies.

logo small

State-of-the-Art Manufacturing Facility

Our facility consists of 50,000 square feet, located adjacent to the Sarasota/Bradenton International Airport, Sarasota, Florida, USA. Cambryn Biologics operates a state-of-the-art manufacturing facility.

Contact Details

Address: 600 Tallevast Rd.
Suite 201 Sarasota, FL 34243

Phone: (941) 355-7400

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.